United we are in rolling up our sleeves

#StopTheSpread with #LargestVaccineDrive

India’s COVID-19 Vaccination Programme

In India, there are two vaccines that have been approved by the Drugs Controller General of India — Covishield and COVAXIN. These two vaccines are being produced in large numbers to be able to vaccinate the entire Indian population against the Novel Coronavirus. The government aims to vaccinate 300 million people by July.

The Covishield vaccine was created by the University of Oxford, together with AstraZeneca, and is being manufactured by the Serum Institute of India for Indian residents. COVAXIN, on the other hand, is India’s first indigenous COVID-19 vaccine developed in partnership with the Indian Council of Medical Research (ICMR).

1.1 crore vials of Covishield and 55 lakh vials of COVAXIN have been ordered by the Government of India. These have been assigned to the different centres in each state and Union Territory. On January 16, 2021, Day 1 of the nationwide COVID-19 Vaccination Programme, close to two lakh healthcare workers were vaccinated.

Over the past month or two, India has seen a dip in the number of new cases per day. On January 18, 2021, India recorded 13,788 new cases. This is significantly low compared to our highest record of 97,894 new cases on September 17, 2020. This significant lowering of our numbers indicates that we are closer now to flattening the curve than ever before.

#GetTheShot and #StopTheSpread for a #CovidFreeIndia

COVID-19 Statistics in India as of (01.03.2021)

The first case of the COVID-19 pandemic in the Indian state of Tamil Nadu was reported on 7 March 2020. Tamil Nadu has the fourth highest number of confirmed cases in India after Karnataka, Andhra Pradesh and Maharashtra. All 37 districts of the state are affected by the pandemic, with capital district Chennai being the worst affected.

11.10M Total cases
10.80M Recovered
1570K Deaths

Who will get the vaccine in Phase I

As there are only a limited doses of both vaccines available at the moment for Phase I, here is the order of priority of who will receive the vaccine first while more is being created for Phase II.

0crore population Healthcare workers
0crore population Frontline workers
0crore population Persons above 60 years of age
0crore population PERSONS BETWEEN 45-50 YEARS WITH COMORBIDITIES

Register for the vaccine and join us in the largest vaccine drive

GET IN TOUCH WITH US